艾美疫苗(06660.HK)13價肺炎結合疫苗已提交上市註冊預申請

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

艾美疫苗(06660.HK)13價肺炎結合疫苗已提交上市註冊預申請

阿思達克 03-03 21:49

艾美疫苗(06660.HK)公布，2月29日，集團13價肺炎結合疫苗，已提交上市註冊預申請，計劃本年度正式完成申報上市。 13價肺炎結合疫苗主要用於6周齡至5歲嬰幼兒和兒童，預防該疫苗包含的13種肺炎血清型引起的侵襲性疾病(包括菌血症性肺炎、腦膜炎、敗血症和菌血症)。

艾美疫苗(06660.HK)

Relevant Stocks

艾美疫苗(06660.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

艾美疫苗(06660.HK)13價肺炎結合疫苗已提交上市註冊預申請

Services

About Us

Agreement Statement